Product Code: RP-ID-10170475 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10170475
Market Overview:
Global Prosthetic heart valve Market Size study, by type of valve (Transcatheter Heart Valves, Tissue Heart Valves, Mechanical Heart Valves) and Regional Forecasts 2019-2026
Global Prosthetic heart valve Market is valued approximately USD 5.5 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 12.90% over the forecast period 2019-2026. Global artificial or prosthetic heart valve deals in implantation of artificial heart in the patients suffering from heart related disorder. Surging geriatric population and growing prevalence of heart valve diseases are key driving forces of market growth. For instance, as per the Society of Thoracic Surgeons, about 5 million people in America are diagnosed with heart valve diseases every year and causes more than 22,000 mortality in America owing to heart valve diseases. Unhealthy lifestyle and lack of physical activities causes various cardiac diseases and pathological disorders. In addition, increasing government funding towards research and development in heart valve diseases is contributing towards market growth. Increasing demand for minimally invasive procedures and technological advancement are also leveraging about more effective heart valve devices. However, high cost and risk associated with Transcatheter Aortic Valve Replacement (TAVR) procedures and strict approval process are hindering factor for the market growth over the forecast period of 2019-2026.
The regional analysis of global Prosthetic heart valve market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to increasing elderly population, increasing product approvals and escalating heart diseases are leading the market growth in the region. Moreover, Asia Pacific is projected to be the fastest growing region in prosthetic heart valve market over the forecast period. Factors such as increasing disposable incomes and growing prevalence of high occurrence of heart valve diseases, ageing population along with improvement in healthcare infrastructure contributes to the fastest growth rate of Asia Pacific artificial heart valve market during the forecast period.
Major market player included in this report are:
Medtronic plc
Edwards Lifesciences Corporation
Boston Scientific Corporation
St. Jude Medical, Inc.
LivaNova PLC
Symetis SA
Jenavalve Technology, Inc.
CryoLife, Inc.
TTK Healthcare Limited
Colibri Heart Valve, LLC
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By type of valve
Transcatheter Heart Valves
Tissue Heart Valves
Mechanical Heart Valves
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026
Target Audience of the Global Prosthetic heart valve Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Edwards Lifesciences Corporation
Boston Scientific Corporation
St. Jude Medical, Inc.
LivaNova PLC
Symetis SA
Jenavalve Technology, Inc.
CryoLife, Inc.
TTK Healthcare Limited
Colibri Heart Valve, LLC
Related Reports
Proof of Quality & Reliability
